MedPath

Benzylpenicillin

Generic Name
Benzylpenicillin
Brand Names
Bicillin, Bicillin L-A, Pfizerpen
Drug Type
Small Molecule
Chemical Formula
C16H18N2O4S
CAS Number
61-33-6
Unique Ingredient Identifier
Q42T66VG0C
Background

Benzylpenicillin (Penicillin G) is narrow spectrum antibiotic used to treat infections caused by susceptible bacteria. It is a natural penicillin antibiotic that is administered intravenously or intramuscularly due to poor oral absorption. Penicillin G may also be used in some cases as prophylaxis against susceptible organisms.

Natural penicillins are considered the drugs of choice for several infections caused by susceptible gram positive aerobic organisms, such as Streptococcus pneumoniae, groups A, B, C and G streptococci, nonenterococcal group D streptococci, viridans group streptococci, and non-penicillinase producing staphylococcus. Aminoglycosides may be added for synergy against group B streptococcus (S. agalactiae), S. viridans, and Enterococcus faecalis. The natural penicillins may also be used as first or second line agents against susceptible gram positive aerobic bacilli such as Bacillus anthracis, Corynebacterium diphtheriae, and Erysipelothrix rhusiopathiae. Natural penicillins have limited activity against gram negative organisms; however, they may be used in some cases to treat infections caused by Neisseria meningitidis and Pasteurella. They are not generally used to treat anaerobic infections. Resistance patterns, susceptibility and treatment guidelines vary across regions.

Indication

For use in the treatment of severe infections caused by penicillin G-susceptible microorganisms when rapid and high penicillin levels are required such as in the treatment of septicemia, meningitis, pericarditis, endocarditis and severe pneumonia.

Associated Conditions
Actinomycosis, Acute Rheumatic Fever, Anthrax, Bloodstream Infections (BSI), Clostridium Botulinum Toxin Adverse Reaction, Diphtheria, Empyema, Endocarditis, Endocarditis caused by Erysipelothrix infections, Fusospirochetosis, Gas Gangrene, Gonococcal infections, Gram-Negative Bacterial Infections, Haverhill fever, Listeria infection, Meningitis, Meningococcal Meningitis, Pasteurella infections, Pericarditis, Pneumonia, Syphilis, Tetanus, Rat bite fever

Single Dose Intravenous Antibiotics for Complicated Urinary Tract Infections in Children

First Posted Date
2021-05-06
Last Posted Date
2025-05-13
Lead Sponsor
Murdoch Childrens Research Institute
Target Recruit Count
452
Registration Number
NCT04876131
Locations
🇦🇺

Women and Children's Hospital, Adelaide, South Australia, Australia

🇦🇺

Monash Health, Melbourne, Victoria, Australia

🇦🇺

Royal Children's Hospital, Parkville, Victoria, Australia

and more 2 locations

Penicillin Against Flucloxacillin Treatment Evaluation

Phase 4
Withdrawn
Conditions
Staphylococcus Aureus
Interventions
First Posted Date
2018-08-15
Last Posted Date
2022-11-16
Lead Sponsor
The University of Queensland
Registration Number
NCT03632642
Locations
🇦🇺

Brisbane Private Hospital, Brisbane, Queensland, Australia

Bicillin L-A vs Placebo for the Treatment of Chronic, Plaque-Type Psoriasis Unresponsive to Topical Medications

Phase 2
Terminated
Conditions
Psoriasis
Interventions
First Posted Date
2007-01-29
Last Posted Date
2015-04-21
Lead Sponsor
University of Tennessee
Target Recruit Count
5
Registration Number
NCT00427609
Locations
🇺🇸

University of Tennessee Health Science Center, Memphis, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath